Jazz Pharmaceuticals (JAZZ) Q1 2023 Earnings

10MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.07
1.68
3.42
5.17

Details

Expected EPS
4.24
Actual EPS
3.95
Surprise EPS
-0.29
Surprise Percent
+6.84%

Description

Jazz Pharmaceuticals (JAZZ) has reported earnings of 3.95 per share for Q1 2023.

0 Comments

Share your thoughts